The 14 references in paper I. Asherova K., S. Monakhova I., M. Ershova G., S. Angelova N., E. Medvedeva N., И. Ашерова К., С. Монахова И., М. Ершова Г., С. Ангелова Н., Е. Медведева Н. (2014) “Распространенность и источники возможного инфицирования больных Achromobacter хylosoxidans и Stenotraphomonas maltophilia в региональном центре муковисцидоза // Prevalence and possible sources of Achromobacter хylosoxidans and Stenotraphomonas maltophilia infection at a cystic fibrosis center” / spz:neicon:pulmonology:y:2012:i:2:p:65-70

1
LiPuma J.J. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 2003; 24: 681–692.
(check this in PDF content)
2
Hoiby N., Pressler T.Emerging pathogens in cystic fibrosis. Cyst. Fibros. Monograph. 2006; 35 (11): 66–78.
(check this in PDF content)
3
Муковисцидоз. Ранняя диагностика и лечение. / Капранов Н.И., Каширская Н.Ю., Толстова В.Д. и др. М.: ГЭОТАР-Медиа; 2008.
(check this in PDF content)
4
Early intervention and prevention of lung disease in cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2004; 3 (2): 67–91.
(check this in PDF content)
5
Smyth A. Update on treatment of pulmonary exacerbation in cystic fibrosis. Curr. Opin. Pulm. Med. 2006; 12: 440–444.
(check this in PDF content)
6
Goss C.H., Otto K., Aitken M.L. et al. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 356–361.
(check this in PDF content)
7
Goss C.H., Mayer*Hamblett N., Aitken M.L. et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004; 59: 955–959.
(check this in PDF content)
8
Cystic fibrosis in children and adults. The Leeds method of management.: St. James's University Hospital, UK; 2008. November 7.
(check this in PDF content)
9
Baets F., Schelstraete P., van Daele S. et al. Achromobacter хylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 2007; 6 (1): 75–78.
(check this in PDF content)
10
Brown B. et al.In: The 22th Annual North American Cystic Fibrosis Foundation Conference (NACFC). Orlando, Florida; 2008; abs. 359.
(check this in PDF content)
11
Hansen C.R., Pressler T., Nielsen K.G. et al. Inflammation in Achromobacter хylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010; 9 (1): 51–58.
(check this in PDF content)
12
Daele S., Verhelst R., Claeys G. et al.Shared genotypes of Achromobacter хylosoxidans strains isolated from patients at cystic fibrosis rehabilitation center. J. Clin. Microbiol. 2005; 43: 2998–3002.
(check this in PDF content)
13
Balfour*Lynn I.M., Elborn J.S.Respiratory disease: infection. In: Hodson M., Geddes D., Bush A., eds. Cystic fibrosis, 3rd ed. London; 2007. 137–159.
(check this in PDF content)
14
Lee T.W., Brownlee K.G., Conway S.P. et al.Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2003; 2: 29–34. Информация об авторах
(check this in PDF content)